These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 1772323
21. Voltage- and frequency-dependent modulation of L-type Ca2+ channel by MPC-1304, a novel calcium antagonist in guinea-pig hearts. Sunami A, Kanno T, Kanda A. Arch Int Pharmacodyn Ther; 1995; 330(2):151-64. PubMed ID: 8861709 [Abstract] [Full Text] [Related]
22. An electrophysiological comparison of a novel class Ic antiarrhythmic agent, NIK-244 (ethacizin) and flecainide in canine ventricular muscle. Satoh H, Ishii M, Hashimoto K. Br J Pharmacol; 1989 Nov; 98(3):827-32. PubMed ID: 2511994 [Abstract] [Full Text] [Related]
23. Antiarrhythmic and electrophysiological actions of flecainide, bepridil and amiodarone on isolated heart preparations during controlled hypoxia. Dietrich H, Borchard U, Hafner D, Hirth C. Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):267-82. PubMed ID: 3875326 [Abstract] [Full Text] [Related]
24. Electrophysiological effects of maprotiline, a tetracyclic antidepressant agent, on isolated cardiac preparations. Igawa O, Kotake H, Kurata Y, Saitoh M, Fujimoto Y, Hasegawa J, Mashiba H. J Cardiovasc Pharmacol; 1988 Feb; 11(2):167-73. PubMed ID: 2452310 [Abstract] [Full Text] [Related]
25. Effect of flecainide on action potentials and alternating current-induced arrhythmias in mammalian myocardium. Borchard U, Boisten M. J Cardiovasc Pharmacol; 1982 Feb; 4(2):205-12. PubMed ID: 6175802 [Abstract] [Full Text] [Related]
26. Flecainide alters the cardiac microscopic activation pattern. An in-vitro study using voltage sensitive dyes. Dhein S, Hartbauer M, Müller W, Windisch H, Salameh A, Tritthart HA. Pharmacol Res; 1996 Feb; 34(3-4):125-30. PubMed ID: 9051703 [Abstract] [Full Text] [Related]
27. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration. Winslow E, Campbell JK. J Cardiovasc Pharmacol; 1991 Dec; 18(6):911-7. PubMed ID: 1725906 [Abstract] [Full Text] [Related]
29. Effects of combined use of class I antiarrhythmic agents on Vmax of guinea-pig ventricular muscles. Toyama J, Kawamura T, Kodama I. Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():801-4. PubMed ID: 1931757 [Abstract] [Full Text] [Related]
30. [A design of the electrophysiological model on the action of antiarrhythmic agent in hypoxic condition and the electrophysiological study of flecainide]. Koh Y. Nihon Ika Daigaku Zasshi; 1991 Feb; 58(1):86-95. PubMed ID: 1902236 [Abstract] [Full Text] [Related]
33. Effects of midaglizole, a new hypoglycaemic drug on the electrophysiological properties of guinea-pig papillary muscle. Noguchi N, Hasegawa J, Mashiba H. Br J Pharmacol; 1991 Jun; 103(2):1556-60. PubMed ID: 1884109 [Abstract] [Full Text] [Related]
34. Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: differential actions of class Ib and Ic agents. Campbell TJ, Wyse KR, Hemsworth PD. J Cardiovasc Pharmacol; 1991 Jul; 18(1):51-9. PubMed ID: 1719292 [Abstract] [Full Text] [Related]
35. Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles. Ravens U, Schöpper HP. Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):232-9. PubMed ID: 1692975 [Abstract] [Full Text] [Related]